Keyphrases
Antiestrogen
88%
Breast Cancer Cells
88%
Extrachromosomal DNA
65%
4-hydroxytamoxifen
63%
Ionizing Radiation
63%
Apoptosis
58%
Mifepristone
58%
Double Minute Chromosomes
58%
4-OHT
58%
Circular DNA
50%
Radiation Therapy
46%
Antiestrogen Resistance
45%
Multidrug Resistance Protein 1 (MDR1)
44%
Tumor Cells
42%
Combination Therapy
41%
Induced Cell Death
40%
Episome
38%
Drug Resistance Gene
38%
Estrogen Receptor-positive Breast Cancer
38%
Resistant Breast Cancer
34%
Oncogene
31%
Estrogen Receptor
28%
MDR1 Gene
28%
Radiation Effects
28%
In Situ
25%
Monotherapy
25%
Antiprogestins
22%
Autophagy
22%
Macroautophagy
22%
Growth Arrest
22%
Retinoblastoma Protein
21%
ER+ Breast Cancer
20%
DNA-dependent Protein Kinase (DNA-PK)
19%
Phase II Study
19%
Induced Apoptosis
19%
Vinblastine
19%
Human Breast Cancer Cells
19%
Tumor Bed
19%
MEK1
19%
Transforming Growth factor-β1 (TGF-β1)
19%
Chemotherapy Alone
19%
Transitional Cell Carcinoma
19%
Fibrosarcoma
19%
Radiation Response
19%
Enhanced Cytotoxicity
19%
Human Breast Cancer
19%
Resistance Mechanisms
19%
Caspase Activation
19%
Colchicine
19%
Estrogen Receptor-negative
19%
Medicine and Dentistry
Antiestrogen
58%
Cancer Cell
58%
Programmed Cell Death
45%
Breast Cancer
43%
Radiation Therapy
38%
Autophagy
26%
Ionizing Radiation
24%
Estrogen Receptor
22%
Growth Disorder
21%
Estrogen Receptor Positive Breast Cancer
19%
Drug Resistance
19%
Episome
19%
Extrachromosomal DNA
19%
Enzyme Active Site
19%
Epidermal Growth Factor Receptor
19%
Transitional Cell Carcinoma
19%
Oncogene
19%
DNA Dependent Protein Kinase
19%
Caspase
19%
Mitoguazone
19%
Lumpectomy
19%
Upregulation
19%
MAPK1
19%
Urinary Tract
19%
Vinblastine
19%
Neoplasm
19%
Mifepristone
19%
Double Minute Chromosome
19%
Tumor Cell
19%
Radiation Response
19%
Multidrug Resistance Protein 1
14%
Arm
12%
Non-Homologous End Joining
12%
Phosphotransferase
12%
Micronucleus
9%
Gene Dosage
9%
Cell Line
9%
Malignant Neoplasm
8%
Antigestagen
7%
Disease
6%
Tamoxifen
6%
Quadrantectomy
6%
Cancer
6%
Side Effect
6%
Surgical Site
6%
Cisplatin
6%
Histone H2AX
6%
Microinjection
6%
Alpha Chain
6%
Double Stranded DNA
6%
Pharmacology, Toxicology and Pharmaceutical Science
Antiestrogen
100%
Breast Cancer
95%
Afimoxifene
61%
Mifepristone
58%
Estrogen Receptor
49%
Estrogen Receptor Positive Breast Cancer
41%
Combination Therapy
40%
Caspase
31%
Monotherapy
24%
Retinoblastoma Protein
21%
Growth Disorder
21%
Cytotoxicity
21%
Neoplasm
20%
Transitional Cell Carcinoma
19%
Vinblastine
19%
Mitoguazone
19%
Epidermal Growth Factor Receptor
19%
Prostate Cancer
19%
Hyperthermia
19%
Antigestagen
18%
Hormone Cancer Therapy
16%
Cytostatic Agent
12%
Tamoxifen
10%
Malignant Neoplasm
8%
Progesterone Receptor
6%
Remission
6%
Disease
6%
Side Effect
6%
Small Interfering RNA
6%
Cisplatin
6%
Patient History of Chemotherapy
6%
Active Metabolite
5%